Table 5.

Future Directions for the Study Of Erlotinib in Pancreatic Cancer

Correlation between skin rash and the prescribed 100-mg dose Dose escalation to the development of skin rash Treatment of relapsed advanced disease Patient selection according to biomarkers Treatment of locally advanced pancreatic cancer Treatment of early-stage pancreatic cancer